AVANIR PHARMACEUTICALS -CL A
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for AVANIR PHARMACEUTICALS -CL A Cmn, CUSIP 05348P951.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for AVANIR PHARMACEUTICALS -CL A Cmn, CUSIP 05348P951.